Comparative Effects on Fetal Hematopoiesis and Placental Inflammation From Mesenchymal and Hematopoietic Stem Cells as Agents of Transamniotic Stem Cell Therapy (TRASCET) in a Syngeneic Model of Intrauterine Growth Restriction
Author / Expert
Kamila Moskowitzova, Abbie E. Naus, Ina Kycia, Tanya T. Dang, Yash V. Shroff, Emilia Bletsas, Kaitlin Mullin, David Zurakowski, Dario O. Fauza
Topic overview
We compared transamniotic stem cell therapy (TRASCET) using either mesenchymal (MSCs) or hematopoietic (HSCs) stem cells on fetal hematopoiesis in a syngeneic model of intrauterine growth restriction (IUGR).
Comments